Room for innovation?

ONdrugDelivery provides it’s readers with the latest industry information, intelligence and insights about the ideas, technologies, services and products the global pharma and biopharma sector are developing.

As a growing number of biologics are seeing their patent-exclusivity period expire, the window of opportunity for biosimilars to enter the market continues to expand. The increased competition that will ensue typically entails a reduction in the cost of the affected therapies. So, is there room for innovation? Find out more on page 24-25.